AMANDA HARE: Open Payments
NPI 1245748029 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,649 in 117 payments from 26 companies in 2025. Trend: 2023 $1,044 · 2024 $4,371 · 2025 $20,649
Speaker / faculty: $15,331Food & beverage: $3,060Travel & lodging: $2,258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $18,344 |
| ACADIA Pharmaceuticals Inc | 17 | $438 |
| Amneal Pharmaceuticals LLC | 10 | $377 |
| Merz Pharmaceuticals, LLC | 3 | $217 |
| Abbott Laboratories | 2 | $191 |
| Supernus Pharmaceuticals, Inc. | 9 | $190 |
| TG Therapeutics, Inc. | 3 | $140 |
| Eisai Inc. | 1 | $121 |
| GENZYME CORPORATION | 2 | $62 |
| Alexion Pharmaceuticals, Inc. | 2 | $58 |
Products named: VYALEV, NUPLAZID, CREXONT, INBRIJA, INFINITY, Qelbree, BRIUMVI, Leqembi.
Industry payments across SC — which companies pay providers there.
